Upgrade to SI Premium - Free Trial

Needham Downgrades Esperion Therapeutics (ESPR) to Hold

May 4, 2026 3:11 PM
Needham analyst Serge Belanger downgraded Esperion Therapeutics (NASDAQ: ESPR) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Downgrades